October 3, 2016

Dr. Daldrup-Link's work has been featured in the Stanford Medicine News, after its publication in Nature Nanotechnology on Sept. 26! What an honor for Dr. Daldrup-Link and her team. 

The team found that the FDA approved, commercially available, injectable iron supplement, ferumoxytol, activated macrophages and caused them to begin attacking cancer cells in mice. As you may imagine, these results suggest several possible applications in human trials.